Fresenius Medical Care AG & Co. (FMS) Given News Impact Rating of 0.23

Media stories about Fresenius Medical Care AG & Co. (NYSE:FMS) have been trending somewhat positive recently, according to Alpha One Sentiment Analysis. The research firm, a unit of Accern, scores the sentiment of media coverage by analyzing more than twenty million blog and news sources in real time. Alpha One ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Fresenius Medical Care AG & Co. earned a news sentiment score of 0.23 on Alpha One’s scale. Alpha One also assigned media stories about the company an impact score of 0 out of 100, indicating that recent media coverage is extremely unlikely to have an effect on the company’s share price in the near future.

Shares of Fresenius Medical Care AG & Co. (NYSE:FMS) traded up 0.21% during midday trading on Thursday, hitting $42.84. The stock had a trading volume of 79,970 shares. Fresenius Medical Care AG & Co. has a 12 month low of $38.05 and a 12 month high of $47.52. The stock’s 50-day moving average is $42.01 and its 200-day moving average is $41.16. The stock has a market cap of $26.24 billion, a PE ratio of 21.10 and a beta of 0.53.

Fresenius Medical Care AG & Co. (NYSE:FMS) last issued its quarterly earnings results on Wednesday, February 22nd. The company reported $0.63 EPS for the quarter, topping analysts’ consensus estimates of $0.62 by $0.01. The business earned $4.69 billion during the quarter, compared to analysts’ expectations of $4.74 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.56% and a net margin of 6.67%. The business’s quarterly revenue was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.04 earnings per share. Equities analysts anticipate that Fresenius Medical Care AG & Co. will post $2.55 EPS for the current year.

A number of equities research analysts recently commented on the company. Sanford C. Bernstein reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research report on Sunday, March 12th. DZ Bank AG reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a research report on Tuesday, March 7th. Zacks Investment Research lowered Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a research report on Friday, February 24th. Finally, Societe Generale lowered Fresenius Medical Care AG & Co. from a “buy” rating to a “hold” rating in a research report on Friday, February 24th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $46.00.

WARNING: “Fresenius Medical Care AG & Co. (FMS) Given News Impact Rating of 0.23” was published by WKRB News and is owned by of WKRB News. If you are viewing this news story on another domain, it was illegally stolen and republished in violation of US and international copyright & trademark laws. The original version of this news story can be accessed at http://www.wkrb13.com/markets/2065316/fresenius-medical-care-ag-co-fms-given-news-impact-rating-of-0-23.html.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA is a kidney dialysis company. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company’s segments include North America Segment, the Europe, Middle East and Africa (EMEA) Segment, the Asia-Pacific Segment and the Latin America Segment.

5 Day Chart for NYSE:FMS

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2065316/fresenius-medical-care-ag-co-fms-given-news-impact-rating-of-0-23.html

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.